News and Events

MAX BioPharma, Inc. and Revilico, Inc. announced their collaboration in studying the mechanisms of action, performing lead optimization, and...

MAX BioPharma Reports on Oxy210’s Inhibition of Hepatic Expression of Senescence-Associated, Pro-Fibrotic, and Pro-Inflammatory Genes in Mice During...

MAX BioPharma reports on the Inhibition of Atherosclerosis in Hyperlipidemic Mice and Inflammatory Responses of Vascular Cells by its Oxysterol Drug...

https://www.prnewswire.com/news-releases/metaba-and-max-biopharma-announce-breakthrough-progress-on-next-generation-oxysterol-based-antibiotics-302379...

MAX BioPharma in collaboration with Metaba will be presenting at Biocom California's 15th Annual Global Life Science Partnering & Investor...